(S1 (S (S (VP (NN Mind) (NP (DT the) (NN GAP) (: :) (NN Wnt) (NNS steps)) (PP (IN onto) (NP (DT the) (NN mTORC1) (NN train))))) (. .)))
(S1 (S (S (NP (DT The) (NN TSC1/2) (NN tumor-suppressor) (NN complex)) (VP (VBZ controls) (NP (NN protein) (NN synthesis)) (PP (IN through) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN mTOR))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NP (DT this) (NN issue)) (PP (IN of) (NP (NN Cell))))) (, ,) (NP (NP (NNP Inoki) (FW et) (FW al.)) (PRN (-LRB- -LRB-) (NP (NN 2006)) (-RRB- -RRB-))) (VP (VBP report) (SBAR (IN that) (S (NP (DT the) (NNS kinases) (NP (NP (NN GSK3)) (CC and) (NP (NN AMPK)))) (VP (VBP cooperate) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN TSC2))))) (S (VP (TO to) (VP (VB inhibit) (NP (NN mTOR) (NN activity)))))))))) (. .)))
(S1 (S (S (ADVP (RB Surprisingly)) (, ,) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NN TSC2))) (PP (IN by) (NP (NN GSK3)))) (VP (VBZ is) (ADVP (RB markedly)) (VP (VBN suppressed) (PP (IN by) (NP (NN Wnt) (NN signaling)))))) (. .)))
(S1 (S (S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NNS components)) (PP (IN of) (NP (DT the) (NN mTOR) (NN pathway)))) (VP (MD may) (VP (VB be) (NP (NP (JJ therapeutic) (NNS targets)) (PP (IN for) (NP (NP (NNS diseases)) (VP (VBN linked) (PP (TO to) (NP (JJ hyperactive) (NN Wnt) (NN signaling))))))))))))) (. .)))
